Home/Filings/4/0001638599-19-000793
4//SEC Filing

LaBelle Curt H 4

Accession 0001638599-19-000793

CIK 0001682639other

Filed

Aug 19, 8:00 PM ET

Accepted

Aug 20, 5:21 PM ET

Size

11.8 KB

Accession

0001638599-19-000793

Insider Transaction Report

Form 4
Period: 2019-08-16
LaBelle Curt H
Director10% Owner
Transactions
  • Award

    Stock Option (right to buy)

    2019-08-16+45,25645,256 total
    Exercise: $3.11Exp: 2029-08-16Common Stock (45,256 underlying)
Holdings
  • Common Stock, par value $.0001

    (indirect: By Private Medical Equity, Inc.)
    606,667
  • Common Stock, par value $.0001

    (indirect: By LLC)
    453,333
  • Stock Option (right to buy)

    Exercise: $1.24From: 2015-03-02Exp: 2025-03-02Common Stock (40,000 underlying)
    40,000
  • Stock Option (right to buy)

    Exercise: $1.95Exp: 2027-07-07Common Stock (133,334 underlying)
    133,334
  • Stock Option (right to buy)

    (indirect: By Private Medical Equity, Inc.)
    Exercise: $1.24From: 2015-03-23Exp: 2025-03-23Common Stock (140,000 underlying)
    140,000
  • Common Stock, par value $.0001

    27,985
Footnotes (3)
  • [F1]The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
  • [F2]One-third of the option became exercisable on August 16, 2020 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter.
  • [F3]The option became exercisable as to 3,704 shares on August 7, 2017, and becomes exercisable in equal 3,704 share amounts on each of the 35 one-month anniversaries thereafter.

Issuer

EYENOVIA, INC.

CIK 0001682639

Entity typeother

Related Parties

1
  • filerCIK 0001396235

Filing Metadata

Form type
4
Filed
Aug 19, 8:00 PM ET
Accepted
Aug 20, 5:21 PM ET
Size
11.8 KB